Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alon D Altman

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Gynecologic Oncology|September 10, 2015
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancersAlon D Altman, Sarah E Ferguson, Eshetu G Atenafu, et al.
Gynecologic Oncology Reports|October 10, 2024
Global distribution and career outcomes of international fellows trained in Canadian gynecologic oncology programsOmar Touhami, Lara De Guerke, Ly-Ann Teo Fortin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 8, 2024
Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort studyLaurence Bernard, Gregory R Pond, Laurie Elit, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group StudyChrista Aubrey, Gregory R Pond, Limor Helpman, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Gynecologic Oncology|June 5, 2026
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateGregg Nelson, Alon D Altman, Amy Metcalfe, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
The Lancet. Oncology|July 3, 2020
New approaches to cancer care in a COVID-19 worldJohn Butler, Christian Finley, Charles H Norell, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Gynecologic Oncology|September 10, 2015
Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancersAlon D Altman, Sarah E Ferguson, Eshetu G Atenafu, et al.
Gynecologic Oncology Reports|October 10, 2024
Global distribution and career outcomes of international fellows trained in Canadian gynecologic oncology programsOmar Touhami, Lara De Guerke, Ly-Ann Teo Fortin, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 8, 2024
Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort studyLaurence Bernard, Gregory R Pond, Laurie Elit, et al.
Current Oncology (Toronto, Ont.)|February 24, 2023
Oncologic Outcomes of Surgically Treated Cervical Cancer with No Residual Disease on Hysterectomy Specimen: A 4C (Canadian Cervical Cancer Collaborative) Working Group StudyChrista Aubrey, Gregory R Pond, Limor Helpman, et al.
Journal of Medical Genetics|July 26, 2018
Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmapJeanna M McCuaig, Tracy L Stockley, Patricia Shaw, et al.
Gynecologic Oncology|June 5, 2026
Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateGregg Nelson, Alon D Altman, Amy Metcalfe, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Consensus Statement from the Society of Gynecologic Oncology of Canada on Folate Receptor α Testing in Ovarian CancerKim Ma, Basile Tessier-Cloutier, Alon D Altman, et al.
International Journal of Cancer|December 19, 2022
Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 studyCitadel J Cabasag, Melina Arnold, Mark Rutherford, et al.
Gynecologic Oncology|February 2, 2020
Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based studyCitadel J Cabasag, John Butler, Melina Arnold, et al.
The Lancet. Oncology|July 3, 2020
New approaches to cancer care in a COVID-19 worldJohn Butler, Christian Finley, Charles H Norell, et al.
Pageof 7